HEMATOLOGÍA

2001

Artículos

Bornstein R, García Vela J, Gilsanz F, Auray C, Calés C. Cord blood megakaryocytes do not complete maturation, as indicated by impaired establishment of endomitosis and low expression of G1/S cyclins upon thrombopoietin-induced differentiation. Br J Haematol. 2001;114(2):458-65

Brunet S, Urbano Ispizúa A, Ojeda E, Ruiz D, Moraleda JM, Díaz MA, et al.; Spanish Group of Allogenic-PBT, Spain. Favourable effect of the combination of acute and chronic graft-versus-host disease on the outcome of allogeneic peripheral blood stem cell transplantation for advanced haematological malignancies. Br J Haematol. 2001;114(3):544-50 [doi

Gilsanz F, Escalante F, Auray C, Olbés AG. Treatment of leg ulcers in beta-thalassaemia intermedia: use of platelet-derived wound healing factors from the patient’s own platelets. Br J Haematol. 2001;115(3):710 [doi]

Giménez Mesa E, Martínez Salio A, Porta Etessam J, Berbel García A, Cedena Romero T, Salama Bendoyan P. Leucoencefalopatía posterior reversible en un paciente con linfoma no-Hodgkin tras tratamiento con CHOP. An Med Interna. 2001;18(11):591-3

González M, Barragán E, Bolufer P, Chillón C, Colomer D, Borstein R, et al.; Spanish Programme for the Study and Treatment of Haematological Malignancies (PETHEMA) Group. Pretreatment characteristics and clinical outcome of acute promyelocytic leukaemia patients according to the PML-RAR alpha isoforms: a study of the PETHEMA group. Br J Haematol. 2001;114(1):99-103 [doi]

Román J, Castillejo JA, Jiménez A, Bornstein R, González MG, Rodríguez MC, et al. Hypermethylation of the calcitonin gene in acute lymphoblastic leukaemia is associated with unfavourable clinical outcome. Br J Haematol. 2001;113(2):329-38 [doi

Salar A, Sierra J, Gandarillas M, Caballero MD, Marín J, Lahuerta JJ, et al.; GEL/TAMO Spanish Cooperative Group. Autologous stem cell transplantation for clinically aggressive non-Hodgkin’s lymphoma: the role of preparative regimens. Bone Marrow Transplant. 2001;27(4):405-12 [doi

Urbano Ispizúa A, Brunet S, Solano C, Moraleda JM, Rovira M, Zuazu J, et al.; Spanish Group of Allo-PBT. Allogeneic transplantation of CD34+-selected cells from peripheral blood in patients with myeloid malignancies in early phase: a case control comparison with unmodified peripheral blood transplantation. Bone Marrow Transplant. 2001;28(4):349-54 [doi

.

2002

Artículos

García S, Gómez-Salazar D, García Marcilla A, López Pascual J, Martínez MA, Rubio R. Anemia normocítica normocrómica con reagudizaciones frecuentes en un paciente con SIDA. Enferm Infecc Microbiol Clin. 2002;20(2):88-9

Martínez López J, Ayala R, Albizua Q. Typical chronic myelogenous leukemia with e19a2 BCR/ABL transcript. Report of two cases. Haematologica. 2002;87(8):ELT35.

.

2003

Artículos

Lahuerta JJ, Grande C, Martínez López J, De La Serna J, Toscano R, Ortiz MC, et al. Tandem transplants with different high-dose regimens improve the complete remission rates in multiple myeloma. Results of a Grupo Español de Síndromes Linfoproliferativos/Trasplante Autólogo de Médula Osea phase II trial. Br J Haematol. 2003;120(2):296-303.

Martín Ramos ML, López Pastor M, De la Serna Torroba J, Ayala R, García Alonso L, Barreiro Miranda E. Grupos de riesgo citogenético en la leucemia mieloide aguda: Comparacion de los modelos adoptados por los grupos MRC (Medical Research Council, del Reino Unido) y SWOG (Southwest Oncology Group, de EE.UU.). Med Clin (Barc). 2003;121(4):121-5

Palencia SI, Rodríguez Peralto JL, Castaño E, De la Serna J, Vanaclocha F, Iglesias Díez L. Kaposi’s sarcoma after allogeneic peripheral blood stem cell transplantation. Int J Dermatol. 2003;42(8):647-9.

.

2004

Artículos

Martínez López J, Lahuerta JJ, Salama P, Ayala R, Bautista JM. The use of fluorescent molecular beacons in real time PCR of IgH gene rearrangements for quantitative evaluation of multiple myeloma. Clin Lab Haematol. 2004;26(1):31-5.

.

2005

Artículos

Bornstein R, Flores AI, Montalbán MA, Del Rey MJ, De la Serna J, Gilsanz F. A modified cord blood collection method achieves sufficient cell levels for transplantation in most adult patients. Stem Cells. 2005;23(3):324-34.

.

2006

Artículos

Bernardo I, Castillo Rama M, Paz Artal E, Grande C, Castro Panete MJ. A new HLA-B allele, HLA-B*4068, identified in an Equatorian individual. Tissue Antigens. 2006;68(6):528-30.

Martínez López J, Martínez Sánchez P, García Sanz R, Sarasquete ME, Ayala R, González M, et al. Application of self-quenched JH consensus primers for real-time quantitative PCR of IGH gene to minimal residual disease evaluation in multiple myeloma. J Mol Diagn. 2006;8(3):364-70

Quintela Fandino M, López JM, Hitt R, Gamarra S, Jimeno A, Ayala R, et al. Breast cancer-specific mRNA transcripts presence in peripheral blood after adjuvant chemotherapy predicts poor survival among high-risk breast cancer patients treated with high-dose chemotherapy with peripheral blood stem cell support. J Clin Oncol. 2006;24(22):3611-8

.

2007

Artículos

Mason PJ, Bautista JM, Gilsanz F. G6PD deficiency: The genotype-phenotype association. Blood Rev. 2007;21:267-83. Coorigendum in: Blood Rev. 2010;24(1):49 

.

2008

Artículos

De la Serna J, Montesinos P, Vellenga E, Rayón C, Parody R, León A, et al. Causes and prognostic factors of remission induction failure in patients with acute promyelocytic leukemia treated with all-trans retinoic acid and idarubicin. Blood. 2008;111(7):3395-402

Martínez Sánchez P, Montejano L, Sarasquete ME, García Sanz R, Fernández Redondo E, Ayala R, et al. Evaluation of minimal residual disease in multiple myeloma patients by fluorescent-polymerase chain reaction: the prognostic impact of achieving molecular response. Br J Haematol. 2008;142(5):766-74

Rapado I, Albizúa E, Ayala R, Hernández JA, García Alonso L, Grande S, et al. Validity test study of JAK2 V617F and allele burden quantification in the diagnosis of myeloproliferative diseases. Ann Hematol. 2008;87(9):741-9

Serrano Navarro I, Rodríguez López JF, Navas Espejo R, Pérez-Jacoiste MA, Martínez González MA, Grande C, et al. Linfoma hepático primario. Evolución favorable con quimioterapia combinada con rituximab. Rev Esp Enferm Dig. 2008;100(11):724-8

.

2009

Artículos

Alexandru S, González E, Grande C, Hernández A, Morales E, Praga M, et al. Monotherapy rapamycin in renal transplant recipients with lymphoma successfully treated with rituximab. Transplant Proc. 2009;41(6):2435-7.

Ayala R, Grande S, Albizua E, Crooke A, Meneu JC, Moreno A, et al. Long-term follow-up of donor chimerism and tolerance after human liver transplantation. Liver Transpl. 2009;15(6):581-91.

Ayala RM, Martínez López J, Albízua E, Diez A, Gilsanz F. Clinical significance of Gata-1, Gata-2, EKLF, and c-MPL expression in acute myeloid leukemia. Am J Hematol. 2009;84(2):79-86

Bustelos R, Ayala R, Martínez J, Martín MA, Toledo T, Grande S, et al. Living donor liver transplantation: usefulness of hemostatic and prothrombotic screening in potential donors. Transplant Proc. 2009;41(9):3791-5.

Fernández Marín I, Cuesta Fernández R, Ibero Esparza C, Blanco Echevarría A, Bisbal Pardo O, Marín Mori K. Hemofilia adquirida. Rev Clin Esp. 2009;209(4):208-9

Flores AI, McKenna DH, Montalbán MA, De la Cruz J, Wagner JE, Bornstein R. Consistency of the initial cell acquisition procedure is critical to the standardization of CD34+ cell enumeration by flow cytometry: results of a pairwise analysis of umbilical cord blood units and cryopreserved aliquots. Transfusion. 2009;49(4):636-47

Fuster Ó, Barragán E, Bolufer P, Cervera J, Larráyoz MJ, Jiménez Velasco A, et al. Rapid detection of KIT mutations in core-binding factor acute myeloid leukemia using high-resolution melting analysis. J Mol Diagn. 2009;11(5):458-63

Gamarra S, García Effron G, Monteserín C, López Villar I, Gilsanz F, Martínez López J. beta-Thalassaemia Major in a Spanish Patient due to a Compound Heterozygosity for CD39 C –> T/-28 A –> C. Adv Hematol. 2009;2009:476342

Jeremy KP, Plummer ZE, Head DJ, Madgett TE, Sanders KL, Wallington A, et al. 4.1R-deficient human red blood cells have altered phosphatidylserine exposure pathways and are deficient in CD44 and CD47 glycoproteins. Haematologica. 2009;94(10):1354-61

Martínez López J, Rivero A, Rapado I, Montalbán C, Paz Carreira J, Canales M, et al. Influence of MBL-2 mutations in the infection risk of patients with follicular lymphoma treated with rituximab, fludarabine, and cyclophosphamide. Leuk Lymphoma. 2009;50(8):1283-9

Mateos González ME, De la Cruz Bértolo J, López Laso E, Valdés Sánchez MD, Nogales Espert A. Contenido de hemoglobina reticulocitaria para el diagnóstico de la ferropenia. An Pediatr. 2009;71(2):103–9

Mateos González ME, De la Cruz Bértolo J, López Laso E, Valdés Sánchez MD, Nogales Espert A. Revisión de los parámetros hematológicos y bioquímicos para identificar la ferropenia. An Pediatr. 2009;71(2):95–102

Montesinos P, Díaz Mediavilla J, Debén G, Prates V, Tormo M, Rubio V, et al. Central nervous system involvement at first relapse in patients with acute promyelocytic leukemia treated with all-trans retinoic acid and anthracycline monochemotherapy without intrathecal prophylaxis. Haematologica. 2009;94(9):1242-9

Paiva B, Vidriales M-B, Mateo G, Pérez JJ, Montalbán MA, Sureda A, et al. The persistence of immunophenotypically normal residual bone marrow plasma cells at diagnosis identifies a good prognostic subgroup of symptomatic multiple myeloma patients. Blood. 2009;114(20):4369–72

Sáez AI, García-Cosío M, Sáez AJ, Hernández JM, Sánchez-Verde L, Álvarez D, et al. Identification of biological markers of sensitivity to high-clinical-risk-adapted therapy for patients with diffuse large B-cell lymphoma. Leuk Lymphoma. 2009;50(4):571-81

.

2010

Artículos

Lahuerta JJ, Mateos MV, Martínez López J, Grande C, De la Rubia J, Rosiñol L, et al. Busulfan 12 mg/kg plus melphalan 140 mg/m2 versus melphalan 200 mg/m2 as conditioning regimens for autologous transplantation in newly diagnosed multiple myeloma patients included in the PETHEMA/GEM2000 study. Haematologica. 2010;95(11):1913-20

Martínez López J, Crooke A, Grande S, Ayala R, Jiménez Velasco A, Gamarra S, et al. Real-time PCR quantification of haematopoietic chimerism after transplantation: a comparison between TaqMan and hybridization probes technologies. Int J Lab Hematol. 2010;32(1 Pt 1):e17-25

Mason PJ, Bautista JM, Gilsanz F. Corrigendum to “G6PD deficiency: The genotype-phenotype association”. Blood Rev. 2010;24(1):49. Corrigendum for: Blood Rev. 2007;21:267-83